GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study

Part of paid clinical trials in Scottsdale, Arizona.

Sponsor
W.L.Gore & Associates
Study ID
NCT07166133
Status
Recruiting

Conditions

  • Aortic Arch Aneurysm
  • Aortic Arch Dissection

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • GORE® TAG® Thoracic Branch Endoprosthesis — DEVICE
    Lesions in aortic arch in Zone 0 or Zone 1

Study Details

A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.

Key Dates

First listed
Sep 10, 2025
Start date
Mar 2, 2026
Status verified
Aug 2026
Primary completion
Jul 31, 2028
Completion
Mar 31, 2036

Study Design

Enrollment
125 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device)

Primary Outcome Measure

Number of subjects with index endovascular procedure initiated after (or following) the surgical revascularization procedure [ Time Frame: Index Endovascular Procedure Only ]

Central Contacts

Locations (16)

FacilityCityStateZIPSite coordinators
HonorHealthScottsdaleArizona85251
Hasan Aldailami, MD
480-246-3000
Hasan Aldailami, MD (PRINCIPAL_INVESTIGATOR)
Keck Medical Center of USCLos AngelesCalifornia90033
Sukgu Han, MD
323-442-5849
Sukgu Han, MD (PRINCIPAL_INVESTIGATOR)
Hartford HospitalHartfordConnecticut06102
Akhilesh Jain, MD
860-522-4158
Akhilesh Jain, MD (PRINCIPAL_INVESTIGATOR)
MedStar Washington Hospital CenterWashington D.C.District of Columbia20010
William Yoon, MD
202-877-5975
William Yoon, MD (PRINCIPAL_INVESTIGATOR)
University of Florida Health Heart & VascularGainesvilleFlorida32608
Martin Back, MD
352-273-5484
Martin Back, MD (PRINCIPAL_INVESTIGATOR)
Lakeland Regional Medical CenterLakelandFlorida33805
Mohammed Hassan, MD
863-413-5969
Mohammed Hassan, MD (PRINCIPAL_INVESTIGATOR)
University of South FloridaTampaFlorida33606
Halim Yammine, MD
813-821-8034
Halim Yammine, MD (PRINCIPAL_INVESTIGATOR)
University of North Carolina at Chapel HillChapel HillNorth Carolina27599
Mark Farber, MD
919-966-3391
Mark Faber, MD (PRINCIPAL_INVESTIGATOR)
Duke University Medical CenterDurhamNorth Carolina27710
G. Chad Hughes IV, MD
919-668-0903
G. Chad Hughes IV, MD (PRINCIPAL_INVESTIGATOR)
Thomas Jefferson UniversityPhiladelphiaPennsylvania19107
Cecilia Chin, MD
617-835-9038
Cecilia Chin, MD (PRINCIPAL_INVESTIGATOR)
The Methodist Hospital-HoustonHoustonTexas77030
Marvin Atkins, MD
713-441-5200
Marvin Atkins, MD (PRINCIPAL_INVESTIGATOR)
Baylor Scott & White Research InstitutePlanoTexas75093
Justin Schaffer, MD
469-800-6200
Justin Schaffer, MD (PRINCIPAL_INVESTIGATOR)
Intermountain Medical CenterMurrayUtah84107
Jane He, MD
801-507-4700
Jane He, MD (PRINCIPAL_INVESTIGATOR)
University of Washington Medical CenterSeattleWashington98195
Matthew Sweet, MD
206-598-8487
Matthew Sweet, MD (PRINCIPAL_INVESTIGATOR)
University of Wisconsin - MadisonMadisonWisconsin53792
Kyla Bennett, MD
608-265-4420
Kyla Bennett, MD (PRINCIPAL_INVESTIGATOR)
Medical College of WisconsinMilwaukeeWisconsin53226
Peter Rossi, MD
414-955-1800
Peter Rossi, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Scottsdale, AZ

Related Studies